Sfoglia per Autore
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
2025 Saldarriaga, C; Zannad, F; Mcmullan, C; Xing, A; Gates, D; Anstrom, K; Bonaca, M; Corda, S; Ezekowitz, J; Lam, C; Lewis, E; Lindenfeld, J; Mentz, R; O'Connor, C; Patel, M; Ponikowski, P; Reddy, Y; Rosano, G; Senni, M; Udelson, J; Voors, A; Butler, J
The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS-HF
2025 Kondo, T; Jhund, P; Henderson, A; Claggett, B; Desai, A; Brinker, M; Lay-Flurrie, J; Schloemer, P; Viswanathan, P; Amarante, F; Chiang, C; Filippatos, G; Lam, C; Petrie, M; Senni, M; Schou, M; Verma, S; Voors, A; Von Lewinski, D; Zannad, F; Pitt, B; Vaduganathan, M; Solomon, S; Mcmurray, J
Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial
2025 Bhatt, A; Vaduganathan, M; Claggett, B; Jhund, P; Henderson, A; Lam, C; Senni, M; Shah, S; Desai, A; Voors, A; Zannad, F; Pitt, B; Morris, A; Mueller, K; Scalise, A; Mcmurray, J; Solomon, S
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial
2025 Cunningham, J; Claggett, B; Vaduganathan, M; Desai, A; Jhund, P; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Amarante, F; Lay-Flurrie, J; Rohwedder, K; Goea, L; Berger, M; Mcmurray, J; Solomon, S
Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial
2025 Butt, J; Jhund, P; Henderson, A; Claggett, B; Desai, A; Lam, C; Brinker, M; Schloemer, P; Viswanathan, P; Lage, A; Rohwedder, K; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Vaduganathan, M; Solomon, S; Mcmurray, J
Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial
2025 Butt, J; Jhund, P; Henderson, A; Claggett, B; Desai, A; Lam, C; Mueller, K; Scheerer, M; Viswanathan, P; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Vaduganathan, M; Solomon, S; Mcmurray, J
Heart failure improvement, remission, and recovery: A European Journal of Heart Failure expert consensus document
2025 Hulot, J; Ter Maaten, J; Bayes-Genis, A; Halliday, B; Metra, M; Moura, B; Petrie, M; Savarese, G; Senni, M; Van Linhout, S; Stevenson, L; Mullens, W
Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial
2025 Vaduganathan, M; Claggett, B; Udell, J; Desai, A; Jhund, P; Henderson, A; Lay-Flurrie, J; Amarante, F; Glasauer, A; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Mcmurray, J; Solomon, S
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial
2025 Reddy, Y; Butler, J; Anstrom, K; Blaustein, R; Bonaca, M; Corda, S; Ezekowitz, J; Lam, C; Lewis, E; Lindenfeld, J; Mcmullan, C; Mentz, R; O'Connor, C; Patel, M; Ponikowski, P; Rosano, G; Saldarriaga, C; Senni, M; Udelson, J; Voors, A; Zannad, F
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
2025 Yang, M; Henderson, A; Talebi, A; Atherton, J; Chiang, C; Chopra, V; Comin-Colet, J; Kosiborod, M; Kerr Saraiva, J; Claggett, B; Desai, A; Kolkhof, P; Viswanathan, P; Lage, A; Lam, C; Senni, M; Shah, S; Rohwedder, K; Voors, A; Zannad, F; Pitt, B; Vaduganathan, M; Jhund, P; Solomon, S; Mcmurray, J
Time to Significant Benefit of Finerenone in Patients With Heart Failure
2025 Vaduganathan, M; Claggett, B; Desai, A; Jhund, P; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Mcmurray, J; Solomon, S
The chronic heart failure evolutions: Different fates and routes
2025 Agostoni, P; Chiesa, M; Salvioni, E; Emdin, M; Piepoli, M; Sinagra, G; Senni, M; Bonomi, A; Adamopoulos, S; Miliopoulos, D; Mapelli, M; Campodonico, J; Attanasio, U; Apostolo, A; Pestrin, E; Rossoni, A; Magri, D; Paolillo, S; Corra, U; Raimondo, R; Cittadini, A; Iorio, A; Salzano, A; Lagioia, R; Vignati, C; Badagliacca, R; Filardi, P; Correale, M; Perna, E; Metra, M; Cattadori, G; Guazzi, M; Limongelli, G; Parati, G; De Martino, F; Matassini, M; Bandera, F; Bussotti, M; Re, F; Lombardi, C; Scardovi, A; Sciomer, S; Passantino, A; Santolamazza, C; Girola, D; Passino, C; Karsten, M; Nodari, S; Pompilio, G
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial
2025 Ostrominski, J; Mc Causland, F; Claggett, B; Desai, A; Jhund, P; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Schloemer, P; Brinker, M; Scheerer, M; Mcmurray, J; Solomon, S; Vaduganathan, M
Exercise Right Ventricular-Pulmonary Arterial Coupling and Functional Outcome in Patients Undergoing Surgery for Secondary Ischemic Mitral Regurgitation
2025 Fino, C; Bellavia, D; D'Alonzo, M; Merlo, M; Bruno, V; Magne, J; Caputo, M; Terzi, A; Senni, M; Bichi, S; Simon, C; Sciatti, E; Marchetto, G; Iacovoni, A; Pibarot, P
Obesity update: Cardiovascular risk and therapeutic innovations (focus on semaglutide and tirzepatide)
2025 Di Odoardo, L; Zucchetti, O; Sciatti, E; D'Isa, S; D'Elia, E; Senni, M
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trials
2025 Docherty, K; Buendia Lopez, R; Folkvaljon, F; Boer, R; Chen, J; Hammarstedt, A; Kitzman, D; Kosiborod, M; Langkilde, A; Reicher, B; Senni, M; Wilderäng, U; Verma, S; Cowie, M; Solomon, S; Mcmurray, J
Finerenone in Heart Failure with Improved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial
2025 Pabon, M; Vardeny, O; Vaduganathan, M; Desai, A; Claggett, B; Kulac, I; Jhund, P; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Saldarriaga, C; Petrie, M; Merkely, B; Borentain, M; Mueller, K; Viswanathan, P; Amarante, F; Morris, A; Mcmurray, J; Solomon, S
Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure
2025 Vaduganathan, M; Claggett, B; Kulac, I; Miao, Z; Desai, A; Jhund, P; Henderson, A; Brinker, M; Lay-Flurrie, J; Viswanathan, P; Scheerer, M; Lage, A; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Mcmurray, J; Solomon, S
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction The FINEARTS-HF Randomized Clinical Trial
2025 Desai, A; Jhund, P; Vaduganathan, M; Claggett, B; Cunningham, J; Pabon, M; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Amarante, F; Lay-Flurrie, J; Scheerer, M; Lage, A; Mcmurray, J; Solomon, S
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND study
2025 Kalogeropoulos, A; Hameed, I; Anker, S; Bayes-Genis, A; Bohm, M; Budden, J; Cleland, J; Coats, A; Ezekowitz, J; Filippatos, G; Goudev, A; Khan, M; Lindenfeld, J; Lund, L; Merkely, B; Mentz, R; Metra, M; Moutchia, J; Perrin, A; Ponikowski, P; Priest, E; Rossignol, P; Senni, M; Shaver, C; Waechter, S; Weir, M; Pitt, B; Butler, J
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile